B&L Seeks Preliminary Approval of $40 Million Immunomedics Settlement

Proposed settlement comes after four years of intense litigation.

Block & Leviton today filed a motion seeking preliminary approval of a $40 million settlement in the long-running securities case against Immunomedics (which has since been acquired) and its executives. Additional details about the settlement are available on the case website.

Block & Leviton is co-lead counsel with Robbins, Geller, Rudman & Dowd LLP in this litigation.

Are you a victim of corporate fraud?

Talk to us about your case.

Contact our attorneys for a no-cost case evaluation.

January 20, 2023

More News Stories

June 2, 2023
Securities Sidebar - June 2023

Summer edition of Block & Leviton's newsletter

Read story
December 29, 2022
Kim Evans to Speak at PLI's 2023 M&A Conference

Speakers include members of the Delaware bench

Read story
December 21, 2022
Securities Sidebar: December 2022

Block & Leviton's winter newsletter.

Read story